Financials Exicure, Inc.

Equities

XCUR

US30205M2008

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
0.5001 USD -1.75% Intraday chart for Exicure, Inc. -10.86% -13.82%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022
Capitalization 1 157 246.2 155 20.44 5.709
Enterprise Value (EV) 1 135.7 140.7 97.74 -3.967 4.438
P/E ratio -6.51 x -6.27 x -6.26 x -0.28 x -2.06 x
Yield - - - - -
Capitalization / Revenue 1,331 x 190 x 9.33 x -42.3 x 0.2 x
EV / Revenue 1,150 x 109 x 5.88 x 8.21 x 0.15 x
EV / EBITDA -6.32 x -5.36 x -3.96 x 0.07 x -6.64 x
EV / FCF -10.7 x 18.2 x -3.23 x 0.18 x -0.22 x
FCF Yield -9.38% 5.5% -31% 565% -460%
Price to Book 7.49 x 3.05 x 2.52 x 1.96 x 0.38 x
Nbr of stocks (in thousands) 1,479 2,869 2,920 3,371 4,965
Reference price 2 106.2 85.80 53.10 6.063 1.150
Announcement Date 3/8/19 3/10/20 3/11/21 3/25/22 3/27/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 9.719 0.118 1.296 16.61 -0.483 28.83
EBITDA 1 -11.2 -21.46 -26.22 -24.67 -60.23 -0.668
EBIT 1 -11.44 -21.82 -26.62 -25.44 -61.35 -1.831
Operating Margin -117.66% -18,490.68% -2,053.78% -153.11% 12,702.07% -6.35%
Earnings before Tax (EBT) 1 -12.04 -22.41 -26.3 -24.67 -64.1 -2.373
Net income 1 -12.04 -22.41 -26.3 -24.67 -64.1 -2.582
Net margin -123.87% -18,994.07% -2,029.55% -148.49% 13,271.64% -8.96%
EPS 2 -35.69 -16.32 -13.68 -8.486 -21.70 -0.5589
Free Cash Flow 1 -14.7 -12.72 7.739 -30.26 -22.43 -20.41
FCF margin -151.29% -10,781.25% 597.15% -182.12% 4,643.12% -70.8%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/9/18 3/8/19 3/10/20 3/11/21 3/25/22 3/27/23
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales 1 0.997 0.079 -3.677 2.118 2.565 2.471
EBITDA - - - - - -
EBIT -12.16 -13.86 -23.08 - - -
Operating Margin -1,219.36% -17,546.84% 627.71% - - -
Earnings before Tax (EBT) -12.48 -14.27 -23.53 - - -
Net income -12.48 -14.27 -23.53 - - -
Net margin -1,251.45% -18,062.03% 639.95% - - -
EPS 2 -4.200 -4.800 -8.100 -4.500 -2.100 -1.660
Dividend per Share - - - - - -
Announcement Date 5/12/21 8/12/21 11/19/21 3/25/22 5/16/22 8/15/22
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 20.9 21.3 105 57.3 24.4 1.27
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -14.7 -12.7 7.74 -30.3 -22.4 -20.4
ROE (net income / shareholders' equity) -111% -110% -51.7% -34.7% -176% -19.7%
ROA (Net income/ Total Assets) -29.4% -47.2% -23.1% -14.7% -46.4% -2.6%
Assets 1 40.96 47.45 113.9 167.4 138.2 99.5
Book Value Per Share 2 14.50 14.20 28.10 21.10 3.100 3.000
Cash Flow per Share 2 19.70 17.80 16.90 11.40 9.550 1.730
Capex 1 0.93 0.09 1.08 3.17 0.97 0.01
Capex / Sales 9.53% 79.66% 83.49% 19.09% -200.41% 0.03%
Announcement Date 3/9/18 3/8/19 3/10/20 3/11/21 3/25/22 3/27/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. XCUR Stock
  4. Financials Exicure, Inc.